NCT06311305

Brief Summary

Gallstones have been recognised since antiquity and have been found during autopsies of Egyptian mummies. Following the first successful open cholecystectomy in 1882, it was Eric Muhe, a German surgeon, who performed the first laparoscopic cholecystectomy (Lapara, the flank; and skopein, to examine) in 1985. The common mechanism of gallstone formation includes cholesterol hypersecretion, alteration in intestinal bile salt, cholesterol absorption and gall bladder hypokinesia, which leads to bile cholesterol supersaturation and nucleation. Incidence of CBD stones in cases of cholelithiasis is around 3.4%-15%.2 Choledocholithiasis can either be primary or secondary. Secondary Choledocholithiasis being more common occurs due to stones originating in gallbladder and then migrating through cystic duct to CBD. Primary bile duct stones originate from within bile ducts and are more common in Asian populations. These stones are associated with biliary stasis and bacteria.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

March 6, 2024

Last Update Submit

March 8, 2024

Conditions

Keywords

ERCPLaparoscopiccholecystectomyGallstones

Outcome Measures

Primary Outcomes (4)

  • bile leakage

    yes or no

    2 weeks postoperative

  • operative time

    in hours

    intraoperative

  • intraoperative bleeding

    in cubic centimeters

    intraoperative

  • sepsis

    yes or no

    2 weeks postoperative

Study Arms (1)

early laparoscopic cholecystectomy after ERCP

OTHER

we assess the risks and complications of early laparoscopic cholecystectomy after ERCP

Procedure: Early Laparoscopic cholecystectomy

Interventions

laparoscopic cholecystectomy early after ERCP with assessing the risks and complications

Also known as: laparoscopic cholecystectomy
early laparoscopic cholecystectomy after ERCP

Eligibility Criteria

Age15 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients post ERCP with gall stone.
  • Age 15-70
  • Gender female and male patient.

You may not qualify if:

  • Post ERCP pancreatitis
  • Septicemia
  • Hepatocellular jaundice and End stage liver disease
  • Patient who didn't give informed consent.
  • Patients who refused laparoscopic cholecystectomy.
  • Patients who were not fit for general anesthesia due to various medical illnesses.
  • ERCP for reasons other than stone disease,
  • Contraindications to Laparoscopic cholecystectomy like: Cardiovascular andpulmonary disease, coagulopathies and end-stage liver disease (ESLD).
  • Patients with Carcinoma Gall bladder, Common bile duct strictures, Coagulopathy, previous upper abdominal surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, 82511, Egypt

RECRUITING

MeSH Terms

Conditions

CholelithiasisGallstones

Interventions

Cholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Central Study Contacts

Abdulla M Ahmed, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
NONE (open label single group)
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: we aim to assess if the early laparoscopic cholecystectomy after ERCP can reduce the risks or complications
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Abdulla Mohammed Ahmed Hussein

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 15, 2024

Study Start

March 1, 2024

Primary Completion

August 1, 2024

Study Completion

August 20, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations